Johannes Patzelt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Johannes Patzelt has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Harald F. Langer
Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, European Center for Angioscience (ECAS), Medical Faculty Mannheim, University Medical Centre Mannheim, Heidelberg University, Mannheim, Germany
4 shared publications Annika Becker
Departments of Cardiology and Cardiovascular Medicine University Hospital Eberhard Karls University Tübingen Germany
2 shared publicationsChristian Schlensak
Department of Cardiovascular Surgery University Hospital Eberhard Karls University Tübingen Tübingen Germany
2 shared publications- Christoph Marquetand
Department for Cardiology, Angiology and Intensive Care Medicine, University Clinic Schleswig-Holstein and University Heart Center Luebeck, Luebeck, Germany
2 shared publications - Jan-Christian Reil
Ruhr-Universität Bochum, Herz- und Diabeteszentrum NRW, Klinik für Allgemeine und Interventionelle Kardiologie/Angiologie , Georgstrasse 11, 32547 Bad Oeynhausen, Deutschland
2 shared publications Jürgen Schreieck
Department of Cardiology and Cardiovascular Medicine, University Hospital, Eberhard Karls University, Otfried-Müller-Str. 10, Tübingen, Germany
2 shared publications
Latest Publications
- 21 November 2020
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 32 (1) , 29-38
Reduced left ventricular contractility, increased diastolic operant stiffness and high energetic expenditure in patients with severe aortic regurgitation without indication for surgery
OBJECTIVES: Recent mortality studies showed worse prognosis in patients (ARNS) with severe aortic regurgitation and preserved ejection fraction (EF) not fulfilling the criteria of current guidelines for surgery. The aim of our study was to analyse left ventricular (LV) systolic and diastolic function and mechanical energetics to find haemodynamic explanations for the reduced prognosis of these patients and to seek a new concept for surgery. METHODS: Global longitudinal strain (GLS) and echo-based single-beat pressure–volume analyses were performed in patients with ARNS (LV end-diastolic diameter 50%, GLS > −19% n = 41), with indication for surgery (ARS; n = 19) and in mild hypertensive controls (C; n = 20). Additionally, end-systolic elastance (LV contractility), stroke work and total energy (pressure–volume area) were calculated. RESULTS: ARNS demonstrated significantly depressed LV contractility versus C: end-systolic elastance (1.58 ± 0.7 vs 2.54 ± 0.8 mmHg/ml; P < 0.001), despite identical EF (EF: 59 ± 6% vs 59 ± 7%). Accordingly, GLS was decreased [−15.7 ± 2.7% (n = 31) vs −21.2 ± 2.4%; P < 0.001], end-diastolic volume (236 ± 90 vs 136 ± 30 ml; P < 0.001) and diastolic operant stiffness were markedly enlarged, as were pressure–volume area and stroke work, indicating waste of energy. The correlation of GLS versus end-systolic elastance was good (r = −0.66; P < 0.001). ARNS and ARS patients demonstrated similar haemodynamic disorders, whereas only GLS was worse in ARS. CONCLUSIONS: ARNS patients almost matched the ARS patients in their haemodynamic and energetic deterioration, thereby explaining poor prognosis reported in literature. GLS has been shown to be a reliable surrogate for LV contractility, possibly overestimating contractility due to exhausted preload reserve in aortic regurgitation patients. GLS may outperform conventional echo parameters to predict more precisely the timing of surgery.
- 21 November 2020
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 32 (1) , 29-38
Reduced left ventricular contractility, increased diastolic operant stiffness and high energetic expenditure in patients with severe aortic regurgitation without indication for surgery
OBJECTIVES: Recent mortality studies showed worse prognosis in patients (ARNS) with severe aortic regurgitation and preserved ejection fraction (EF) not fulfilling the criteria of current guidelines for surgery. The aim of our study was to analyse left ventricular (LV) systolic and diastolic function and mechanical energetics to find haemodynamic explanations for the reduced prognosis of these patients and to seek a new concept for surgery. METHODS: Global longitudinal strain (GLS) and echo-based single-beat pressure–volume analyses were performed in patients with ARNS (LV end-diastolic diameter 50%, GLS > −19% n = 41), with indication for surgery (ARS; n = 19) and in mild hypertensive controls (C; n = 20). Additionally, end-systolic elastance (LV contractility), stroke work and total energy (pressure–volume area) were calculated. RESULTS: ARNS demonstrated significantly depressed LV contractility versus C: end-systolic elastance (1.58 ± 0.7 vs 2.54 ± 0.8 mmHg/ml; P < 0.001), despite identical EF (EF: 59 ± 6% vs 59 ± 7%). Accordingly, GLS was decreased [−15.7 ± 2.7% (n = 31) vs −21.2 ± 2.4%; P < 0.001], end-diastolic volume (236 ± 90 vs 136 ± 30 ml; P < 0.001) and diastolic operant stiffness were markedly enlarged, as were pressure–volume area and stroke work, indicating waste of energy. The correlation of GLS versus end-systolic elastance was good (r = −0.66; P < 0.001). ARNS and ARS patients demonstrated similar haemodynamic disorders, whereas only GLS was worse in ARS. CONCLUSIONS: ARNS patients almost matched the ARS patients in their haemodynamic and energetic deterioration, thereby explaining poor prognosis reported in literature. GLS has been shown to be a reliable surrogate for LV contractility, possibly overestimating contractility due to exhausted preload reserve in aortic regurgitation patients. GLS may outperform conventional echo parameters to predict more precisely the timing of surgery.
- 1 December 2019
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 12 (24) , e219-e221
Treatment of Recurrent MR by MitraClip XTR in a Patient With a PASCAL Device
- 1 December 2019
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 12 (24) , e219-e221
Treatment of Recurrent MR by MitraClip XTR in a Patient With a PASCAL Device
- Open Access
- 2 July 2019
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 8 (13) , e011366
Elevated Mitral Valve Pressure Gradient Is Predictive of Long‐Term Outcome After Percutaneous Edge‐to‐Edge Mitral Valve Repair in Patients With Degenerative Mitral Regurgitation (MR), But Not in Functional MR
Background: This study analyzed the effects on long‐term outcome of residual mitral regurgitation ( MR ) and mean mitral valve pressure gradient ( MVPG ) after percutaneous edge‐to‐edge mitral valve repair using the MitraClip system. Methods and Results: Two hundred fifty‐five patients who underwent percutaneous edge‐to‐edge mitral valve repair were analyzed. Kaplan–Meier and Cox regression analyses were performed to evaluate the impact of residual MR and MVPG on clinical outcome. A combined clinical end point (all‐cause mortality, MV surgery, redo procedure, implantation of a left ventricular assist device) was used. After percutaneous edge‐to‐edge mitral valve repair, mean MVPG increased from 1.6±1.0 to 3.1±1.5 mm Hg ( P 4.4 mm Hg was not according to Kaplan–Meier and Cox regression analyses. We then analyzed the cohort with degenerative and that with functional MR separately to account for these different entities. In the cohort with degenerative MR , elevated MVPG was associated with increased occurrence of the primary end point, whereas this was not observed in the cohort with functional MR . Conclusions: MVPG >4.4 mm Hg after MitraClip implantation was predictive of clinical outcome in the patient cohort with degenerative MR . In the patient cohort with functional MR , MVPG >4.4 mm Hg was not associated with increased clinical events.
- 2 July 2019
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 8 (13) , e011366
Open AccessElevated Mitral Valve Pressure Gradient Is Predictive of Long‐Term Outcome After Percutaneous Edge‐to‐Edge Mitral Valve Repair in Patients With Degenerative Mitral Regurgitation (MR), But Not in Functional MR
Background: This study analyzed the effects on long‐term outcome of residual mitral regurgitation ( MR ) and mean mitral valve pressure gradient ( MVPG ) after percutaneous edge‐to‐edge mitral valve repair using the MitraClip system. Methods and Results: Two hundred fifty‐five patients who underwent percutaneous edge‐to‐edge mitral valve repair were analyzed. Kaplan–Meier and Cox regression analyses were performed to evaluate the impact of residual MR and MVPG on clinical outcome. A combined clinical end point (all‐cause mortality, MV surgery, redo procedure, implantation of a left ventricular assist device) was used. After percutaneous edge‐to‐edge mitral valve repair, mean MVPG increased from 1.6±1.0 to 3.1±1.5 mm Hg ( P 4.4 mm Hg was not according to Kaplan–Meier and Cox regression analyses. We then analyzed the cohort with degenerative and that with functional MR separately to account for these different entities. In the cohort with degenerative MR , elevated MVPG was associated with increased occurrence of the primary end point, whereas this was not observed in the cohort with functional MR . Conclusions: MVPG >4.4 mm Hg after MitraClip implantation was predictive of clinical outcome in the patient cohort with degenerative MR . In the patient cohort with functional MR , MVPG >4.4 mm Hg was not associated with increased clinical events.
- Open Access
- 14 May 2019
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 3 (2)
Treatment of a patient with primary mitral regurgitation using the Cardioband® system
A 79-year-old male patient presented with progressive dyspnoea New York Heart Association (NYHA) III. Echocardiography showed a normal left ventricular function (ejection fraction 60%) with severe mitral regurgitation (MR) caused by a prolapse of the P1 and P2 segment of the posterior mitral leaflet (Figure 1A and B). Moreover, there was relevant calcification of the posterior mitral annulus specifically in the P2 segment (Figure 1C). The patient’s case was discussed within our interdisciplinary heart team. Interventional treatment was recommended due to the patient’s comorbidities with impaired clinical status and high frailty. As genesis of MR was primary, MitraClip® implantation was recommended. Because of the anatomy of the valve with a prolapse in the P1/P2 segment difficult leaflet grasping was anticipated. Taking into consideration this complex anatomy, it was recommended to approximate the mitral valve leaflets in a first step by implantation of a Cardioband® to facilitate the consecutive MitraClip® implantation.
- 14 May 2019
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 3 (2)
Open AccessTreatment of a patient with primary mitral regurgitation using the Cardioband® system
A 79-year-old male patient presented with progressive dyspnoea New York Heart Association (NYHA) III. Echocardiography showed a normal left ventricular function (ejection fraction 60%) with severe mitral regurgitation (MR) caused by a prolapse of the P1 and P2 segment of the posterior mitral leaflet (Figure 1A and B). Moreover, there was relevant calcification of the posterior mitral annulus specifically in the P2 segment (Figure 1C). The patient’s case was discussed within our interdisciplinary heart team. Interventional treatment was recommended due to the patient’s comorbidities with impaired clinical status and high frailty. As genesis of MR was primary, MitraClip® implantation was recommended. Because of the anatomy of the valve with a prolapse in the P1/P2 segment difficult leaflet grasping was anticipated. Taking into consideration this complex anatomy, it was recommended to approximate the mitral valve leaflets in a first step by implantation of a Cardioband® to facilitate the consecutive MitraClip® implantation.
- Open Access
- 19 October 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (10) , e0205930
Previous TAVR in patients undergoing percutaneous edge-to-edge mitral valve repair (PMVR) affects improvement of MR
Patients after transcatheter aortic valve replacement (TAVR) and persistent severe mitral regurgitation (MR) are increasingly treated with percutaneous edge-to-edge mitral valve repair (PMVR). The impact of a former TAVR on PMVR procedures is not clear. We retrospectively analyzed 332 patients undergoing PMVR using the MitraClip system with respect to procedural and clinical outcome. 21 of these 332 patients underwent TAVR before PMVR. Intra-procedural transthoracic (TTE) and transesophageal echocardiograms (TEE) immediately before and after clip implantation as well as invasive hemodynamic measurements were evaluated. At baseline, we found a significantly smaller mitral valve anterior-posterior diameter in the TAVR cohort (p < 0.001). A reduction of MR by at least three grades was achieved in a smaller fraction in the TAVR cohort as compared to the cohort with a native aortic valve (p = 0.02). Accordingly, we observed a smaller post-procedural cardiac output in the TAVR cohort (p = 0.02). PMVR in patients who had a TAVR before, is associated with altered MR anatomy before and a reduced improvement of MR after the procedure. Future larger and prospective studies will have to determine, whether a previous TAVR influences long-term clinical outcome of patients undergoing PMVR.
- 19 October 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (10) , e0205930
Open AccessPrevious TAVR in patients undergoing percutaneous edge-to-edge mitral valve repair (PMVR) affects improvement of MR
Patients after transcatheter aortic valve replacement (TAVR) and persistent severe mitral regurgitation (MR) are increasingly treated with percutaneous edge-to-edge mitral valve repair (PMVR). The impact of a former TAVR on PMVR procedures is not clear. We retrospectively analyzed 332 patients undergoing PMVR using the MitraClip system with respect to procedural and clinical outcome. 21 of these 332 patients underwent TAVR before PMVR. Intra-procedural transthoracic (TTE) and transesophageal echocardiograms (TEE) immediately before and after clip implantation as well as invasive hemodynamic measurements were evaluated. At baseline, we found a significantly smaller mitral valve anterior-posterior diameter in the TAVR cohort (p < 0.001). A reduction of MR by at least three grades was achieved in a smaller fraction in the TAVR cohort as compared to the cohort with a native aortic valve (p = 0.02). Accordingly, we observed a smaller post-procedural cardiac output in the TAVR cohort (p = 0.02). PMVR in patients who had a TAVR before, is associated with altered MR anatomy before and a reduced improvement of MR after the procedure. Future larger and prospective studies will have to determine, whether a previous TAVR influences long-term clinical outcome of patients undergoing PMVR.
- 1 December 2015
- Published by Elsevier in International Journal of Cardiology
- Vol. 201, 321-323
Percutaneous mitral valve repair (PMVR) in a patient with recurrence of mitral regurgitation 17years after surgical reconstruction
- 1 December 2015
- Published by Elsevier in International Journal of Cardiology
- Vol. 201, 321-323
Percutaneous mitral valve repair (PMVR) in a patient with recurrence of mitral regurgitation 17years after surgical reconstruction